Abstract

ObjectivesPseudomonas aeruginosa is important pathogens commonly cause nosocomial infections. The occurrence of multi-resistant organisms (MROs) of Pseudomonas aeruginosa strains have been increased worldwide and limiting the therapeutic options. The MRO of Pseudomonas aeruginosa phenotype can be mediated by a variety of resistance mechanisms and highly versatile property to mutate. Therefore the our study aimed to evaluate the resistance pattern of Pseudomonas aeruginosa collected from Riyadh tertiary care hospital, Kingdom of Saudi Arabia. MethodsDuring the period from 2019 to 2021 clinical samples were collected from microbiology lab at King Khalid University Hospital and analysed for the antibiotic susceptibility pattern. ResultsSuggested that the rates of resistance for the three years were higher for isolates collected from patients older than 50 years if its compared with the strains collected from young age. A total of 1024 Pseudomonas aeruginosa isolates were collected during the last three years, the prevalence rate were 44.6%, 32.6% and 22.7% during the period of 2019, 2020, and 2021 respectively. Meanwhile, the highest percentages of multi drug resistance Pseudomonas aeruginosa strains were recovered from body fluids; about 38 (47.5%) out of 80 Pseudomonas aeruginosa isolates were MRO Pseudomonas aeruginosa. The rate of resistances showed that Imipenem was significantly higher in resistant among the clinical isolates (77.8%), then Meropenem (61%), Aztreonam (42%) and Ceftazidime (36%) than other antibiotics. Most of isolates were sensitive to colistin except (2.7%) were resistance. Moreover, antibiotic resistantbacteriahave beenobserved withincreasingfrequency over the pastthree years. ConclusionsThe current study reports that the susceptibility among P. aeruginosa isolates have been decreased in KSA, perhaps due to the massive use of antibiotics, the lack of adherence to approved infection control practices by hospitals, or due to the changes to the public health infrastructure.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call